On Jul. 6, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
On Jun. 29, 2020, Luminex announced that the company had submitted an Emergency Use Authorization request to the…
On Jun. 25, 2020, the Allen Institute announced a new a new $40.5 million collaborative research center in…
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital…
On Jun. 10, 2020, African Americans who smoke are nearly 2.5 times more likely to have a stroke…
On Jun. 9, 2020, people with small airways relative to the size of their lungs may have a…
On Jun. 9, 2020, genetic sequence analysis by the Democratic Republic of the Congo’s (DRC) National Institute of…
On Jun. 9, 2020, an international gnomAD team of over 100 scientists released its first set of discoveries…
On Jun. 8, 2020, researchers at the National Human Genome Research Institute announced they had discovered clues to…
On May 27, 2020, the National Institutes of Health (NIH) Nutrition Research Task Force (NRTF), armed with insights…
On May 27, 2020, an analyses of the largest publicly available catalog of human genomic data revealed new…
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
On May 18, 2020, the National Institutes of Health (NIH) reported that roughly 3 to 5% of children…
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
On May 5, 2020, the U.S. Dept. of Veterans Affairs (VA) announced the Airborne Hazards and Open Burn…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
On Apr. 29, 2020, Windtree Therapeutics announced it has enrolled the first patient into its AEROSURF phase 2b…
On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy),…
On Apr. 21, 2020, University of Oxford announced that it had successfully obtained re-registration of the T-SPOT.TB test…
On Apr. 21, 2020, researchers at the U.S. Department of Veterans Affairs’ (VA) Providence VA Medical Center began…
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
On Apr. 17, 2020, the National Institutes of Health (NIH) announced nearly $290 million of new funding for…
On Apr. 15, 2020, Bellicum Pharma announced closing of the sale of its Houston facility to The University…
On Apr. 10, 2020, Oregon Health & Science University (OHSU) announced that a 68-year-old Oregonian was recovering at…
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…
On Apr. 2, 2020, a study in Neuron offers clues to why autism spectrum disorder (ASD) is more…
On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop a…
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…